Business Description
Biora Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US74319F3055
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | -4.36 | |||||
Debt-to-Equity | -0.47 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -74.5 | |||||
Beneish M-Score | -7.16 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 57.8 | |||||
3-Year EPS without NRI Growth Rate | 54.5 | |||||
3-Year FCF Growth Rate | 72.9 | |||||
3-Year Book Growth Rate | 57.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 10.81 | |||||
9-Day RSI | 22.74 | |||||
14-Day RSI | 30.9 | |||||
6-1 Month Momentum % | -53.6 | |||||
12-1 Month Momentum % | -90.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.28 | |||||
Quick Ratio | 0.28 | |||||
Cash Ratio | 0.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -131.9 | |||||
Shareholder Yield % | 210.05 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -12337.32 | |||||
Net Margin % | -20379.23 | |||||
FCF Margin % | -9033.93 | |||||
ROA % | -288.97 | |||||
ROIC % | -152.24 | |||||
ROC (Joel Greenblatt) % | -3291.88 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 31.24 | |||||
EV-to-EBIT | -0.57 | |||||
EV-to-Forward-EBIT | -0.8 | |||||
EV-to-EBITDA | -0.57 | |||||
EV-to-Forward-EBITDA | -0.8 | |||||
EV-to-Revenue | 104.88 | |||||
EV-to-Forward-Revenue | 109.86 | |||||
EV-to-FCF | -1.17 | |||||
Earnings Yield (Greenblatt) % | -176.01 | |||||
FCF Yield % | -230.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biora Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.501 | ||
EPS (TTM) (€) | -6.637 | ||
Beta | 0.59 | ||
Volatility % | 83.38 | ||
14-Day RSI | 30.9 | ||
14-Day ATR (€) | 0.066977 | ||
20-Day SMA (€) | 0.6465 | ||
12-1 Month Momentum % | -90.68 | ||
52-Week Range (€) | 0.476 - 6.2225 | ||
Shares Outstanding (Mil) | 35.88 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biora Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biora Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Biora Therapeutics Inc Frequently Asked Questions
What is Biora Therapeutics Inc(FRA:4ZU0)'s stock price today?
When is next earnings date of Biora Therapeutics Inc(FRA:4ZU0)?
Does Biora Therapeutics Inc(FRA:4ZU0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |